Brief: Medicinova Reaches Agreement To Participate In Grant-Funded Clinical Trial To Evaluate Mn-166 (Ibudilast) For The Treatment Of Long Covid
16/08/2022 11:50
Aug 16 (Reuters) - MediciNova Inc MNOV.O :
* MEDICINOVA REACHES AGREEMENT TO PARTICIPATE IN
GRANT-FUNDED
CLINICAL TRIAL TO EVALUATE MN-166 (IBUDILAST) FOR THE TREATMENT
OF LONG COVID
Source text for Eikon: ID:nGNX6Ckqhv
Further company coverage: MNOV.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Medicinova
See all newsBrief: 3D Investment Partners Cuts Stake In Medicinova To 9.88% From 11.22%, Filing Shows
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX
MediciNova falls as fatty liver drug misses significance on blood-fat reduction
US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake